• X-energy, Inc. recently submitted its Xe-100 high-temperature gas-cooled reactor design to enter the United Kingdom’s Generic Design Assessment process, a key step in securing UK regulatory approval for future deployment.
• This move deepens X-energy’s collaboration with Centrica on up to 6 GW of advanced nuclear capacity and leverages cross-border regulatory cooperation with U.S. authorities to potentially streamline licensing.
• We’ll now examine how this progress on UK licensing, especially the bid to deploy up to 6 GW of advanced nuclear, shapes X-energy’s investment narrative.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

What Is X-Energy's Investment Narrative?

To own X-energy today, you have to believe that its advanced nuclear platform can convert early partnerships and regulatory progress into long-term commercial fleets, despite heavy losses and capital needs. The UK GDA submission with Centrica fits neatly into that thesis: it reinforces the 6 GW ambition and adds another potential flagship market alongside Dow’s Texas project, but it is unlikely to shift near term catalysts in a major way, given a review timeline stretching to 2029 and a share price that has already fallen sharply this year. The nearer focus is still on U.S. licensing milestones, progress at the TX-1 fuel facility and signs that the recent US$1.02 billion IPO cash is being deployed efficiently, against the key risk that persistent losses of US$389.78 million and project slippage strain the balance sheet.

However, investors also need to weigh how long funding can support those ambitions without clearer paths to cash flow. X-Energy's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.

Exploring Other Perspectives

Two fair value estimates from the Simply Wall St Community span roughly US$9.43 to US$39.86, underlining how far apart views on X-energy sit. When you set that against the recent share price slide and the long-dated UK GDA process, it becomes clear that opinions differ sharply on how licensing risk and heavy losses might shape the company’s eventual performance.

Explore 2 other fair value estimates on X-Energy - why the stock might be worth as much as 86% more than the current price!

Decide For Yourself

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your X-Energy research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free X-Energy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate X-Energy's overall financial health at a glance.

Looking For Alternative Opportunities?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Find 49 companies with promising cash flow potential yet trading below their fair value.
• This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.